Why would a BP pay a premium for Cydy???
Well, lets see.
Certain individuals on the board blame Nader for a poorly designed trial but the drug works.
BP knows if the drug works or not before it even goes to trial- plus , it's proven that it works more and more each day. Just the HIV trials prove that.
It's worth billions.
Here's the thing- you think Nader would even entertain an offer unless it's a sick amount? Nope.
So, as time goes on and it keeps moving up the ladder, it becomes more and more valuable everyday. Nader ain't selling, partnership, maybe.
Everyone better do some DD. The move that Vyera made puts Leronlimab in Pfizers crosshairs!
Market Data 
Markets 
AI
